pharmaphorum

AUGUST 31, 2021

ECAs are being used to support the primary approval, label expansion of their assets and even go/no-go decisions for trials. This uncertainty has understandably given rise to several myths around ECAs that deserve to be dispelled. Myth 1: There are too many challenges with adopting an ECA.

Clinical Trials 89

Clinical Trials Clinical Trials Life Science Trials 89

Cloudbyz

MAY 13, 2023

Overview: Clinical site monitoring metrics and Key Performance Indicators (KPIs) are fundamental tools in the realm of clinical trial management. They provide a way to quantify and evaluate critical aspects of a clinical trial’s performance at individual investigative sites.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Compliance 52

pharmaphorum

DECEMBER 2, 2022

Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and precision medicine targeting more niche patient populations. This emphasises sponsors’ need for enrolment predictability. Country expansion to support enrolment.

Trials 98

Trials Clinical Trials Clinical Trials Clinical Research 98

Drug Discovery World

JANUARY 24, 2023

Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry, but these are more than just buzzwords. The overall virtual clinical trials market is currently valued at $7.8 billion, with a projected growth of 14% per annum 1. We’ve shown that this type of model can work.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

Clinical Trial Podcast

FEBRUARY 23, 2021

Almost everyone I’ve met in clinical research has accidentally discovered this hidden profession. Your interest in science and medicine somehow got you involved in clinical research and clinical trial management. But didn’t you wish you had a crystal clear understanding of “Who’s Who In Clinical Research?”.

Clinical Research 105

Clinical Research Research Clinical Trials Clinical Trials 105

Cloudbyz

MAY 9, 2023

The adoption of Clinical Trial Management Systems (CTMS) by study teams brings numerous benefits, such as streamlined processes, improved efficiency, and better data accuracy. However, the transition to a new system can also present challenges that may impact the user experience.

Clinical Trials 77

Clinical Trials Clinical Trials Trials Compliance 77

ACRP blog

JUNE 15, 2023

Results of clinical trials are only as good as the data upon which they rest. This is especially true in terms of diversity—if most people in a trial are from a certain race or socioeconomic group, then the results may not be broadly applicable.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Nurses 59

ACRP blog

JUNE 15, 2023

Results of clinical trials are only as good as the data upon which they rest. This is especially true in terms of diversity—if most people in a trial are from a certain race or socioeconomic group, then the results may not be broadly applicable.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Nurses 52

XTalks

JANUARY 17, 2024

Understanding this condition and its various manifestations, as well as developing effective treatments, has been the focus of ongoing investigation in lupus clinical research for many years. Frederico Calado: Companies should use RWD throughout the drug lifecycle, starting with informing clinical development plans.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

Olympian Clinical Research

APRIL 18, 2023

To learn more about the causes and treatments for HS, Olympian Clinical Research ( OCR ) is hosting a research study on the condition. If you suffer from hidradenitis suppurativa and are considering participating in an HS research study with OCR, this guide will give you an idea of what to expect. However, the exact cause is unknown.

Research 52

Research Clinical Research Doctors Doctor 52

pharmaphorum

DECEMBER 15, 2021

Going from the vital activity of patient engagement to the more encompassing state of patient centricity requires big steps in the evolution of new-drug discovery, development, and delivery. Let me make clear that patient engagement is essential in its own right. It has been the focus of much of my career as a physician inside the drug industry.

Pharma Companies 145

Pharma Companies Development Medicine Clinical Trials 145

pharmaphorum

DECEMBER 4, 2022

While female leaders should absolutely seek out ways to guide other women in their field, company leadership should also prioritise formalised mentorship programs that support female career progression. Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry.

Development 105

Development Clinical Trials Clinical Trials Business Development 105

Cloudbyz

DECEMBER 31, 2021

What are people talking about when they say “wearables”, “wearable biosensors”, “wearable devices”, or “wearable technology” in clinical trials? There are more reliable wearable options for heart monitoring on a clinical level. Of course, wearable actigraphs are not exclusively fitted to wristbands.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Manufacturing 52

Crucial Data Soutions

JUNE 12, 2019

Although approach differs slightly amongst organizations in clinical research, everyone agrees on this: it’s time for the industry to become more agile. Over the past ten years, we’ve seen things slowly going the way of virtual clinical trials. Active participation from patients is the lifeblood of clinical trials.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Research 40

Drug Discovery World

SEPTEMBER 28, 2022

Ben Folwell, Principal Consultant at Citeline, maps out how AI, swarm learning and open access to clinical data could revolutionise drug discovery. . Artificial intelligence (AI) is notorious for its industry hype, touted to revolutionise the way multiple sectors operate over the next five to 10 years. The simple answer is no.

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

Worldwide Clinical Trials

MAY 1, 2024

For clinical research professionals, this journey often involves reconciling differing feedback from regulatory agencies, each with unique standards, priorities, and expectations. Despite these efforts, variations between regulatory agencies remain, often resulting in divergent feedback that can complicate clinical development strategies.

Clinical Research 138

Clinical Research Trials Research Clinical Trials 138

Drug Discovery World

OCTOBER 4, 2022

The pandemic might have affected the number of clinical trials taking place for cell and gene therapies, with activity decreasing by around 15% compared to 2020, but major therapies such as Novartis’ gene therapy drug for spinal muscular atrophy (SMA) Zolgensma still made it to market. . billion, compared to $19.9

Gene Therapy 52

Gene Therapy Drugs Gene Manufacturing 52

XTalks

NOVEMBER 1, 2023

The revolution in clinical research is here, and it’s embodied by a single, powerful word: “patients.” The inclusion of patients during clinical development is not only a moral imperative but a strategic necessity in modern medical research. So, when is the best time to incorporate the patient voice in clinical development?

Clinical Trials 87

Clinical Trials Clinical Trials Trials Clinical Development 87

Pharmaceutical Technology

FEBRUARY 13, 2023

The continued high level of interest in small molecules presents multiple opportunities to select a candidate that is ‘developable’, with subsequent rapid progression toward first-in-human (FIH) clinical testing. Therefore, it is vital to choose molecules for pharmaceutical development very carefully.

Development 130

Development In-Vivo Clinical Trials Clinical Trials 130

Cloudbyz

MAY 13, 2023

Overview: This comprehensive guide delves into the critical role of Key Performance Indicators (KPIs) in the context of a Clinical Trial Management System (CTMS). With the complexity and high stakes inherent to clinical research, effective management tools are paramount.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Compliance 52

Pharma Marketing Network

JUNE 8, 2020

I come to the pharma space from being a medical operator of clinics for the last 15 to 20 years where we took care of patients with specific disease conditions that were often overlooked. Chronic fatigue fibromyalgia, ADD, ADHD, and service those patients through a series of national clinics. Bob and Mark thanks for joining us today.

Doctors 40

Doctors Doctor Clinical Trials Clinical Trials 40

XTalks

NOVEMBER 19, 2021

Cardiac biomarkers can not only serve important roles in the diagnosis, management and prognosis of cardiac diseases, but they can also be significant tools in evaluating treatments in cardiovascular (CV) clinical trials. In CV clinical trials, cardiac biomarkers are most commonly included in efficacy and safety endpoints.

Clinical Trials 98

Clinical Trials Clinical Trials Trials In-Vitro 98

Cloudbyz

MAY 23, 2023

Over the last decade, the role of nutraceuticals has evolved significantly, transforming from complementary nutrients to clinically-proven therapeutic agents. Over the last decade, the role of nutraceuticals has evolved significantly, transforming from complementary nutrients to clinically-proven therapeutic agents.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research 52

Drug Discovery World

OCTOBER 25, 2023

JV: A key bottleneck in the research and development of a drug is the lengthy experimentation that is required to gain the confidence to run clinical trials. JV: We’ve helped clients save millions of dollars in drug development and significantly decrease their time for clinical application.

Drugs 109

Drugs Pharma Companies Clinical Trials Clinical Trials 109

Cloudbyz

JUNE 10, 2020

If you’ve been involved in a start-up of a clinical study, you’re probably aware of the challenges that come with patient recruitment. Patient recruitment is one of the biggest bottlenecks in clinical research. These delays increase costs, deplete resources, and prolong the time to market introduction. An Area of Opportunity.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Clinical Research 104

Drug Discovery World

OCTOBER 30, 2023

These biomarkers could potentially also be used to select patients most likely to benefit from a drug targeting a specific mechanism, so that smaller, faster, more targeted clinical trials can be designed. RA: You’ve recently announced a collaboration with the University of Oxford to access genotype data on women with endometriosis.

Genome 70

Genome Genomics Genotype Clinical Trials 70

Drug Discovery World

JANUARY 23, 2023

Demonstrating benefits such as fewer side effects and lower cost to enhanced efficacy and accessibility, this emerging therapeutic modality is giving hope to patients and clinicians. The momentum of RNA technologies is apparent in the significant increase in scientific knowledge, IP and deal-making value over recent years.

RNA 98

RNA Genome Genomics Engineer 98

ACRP blog

DECEMBER 20, 2023

The time required to finalize contracts and budgets is among the most pressing challenges in clinical trials. Leverage Existing Language Look for opportunities to use a template or another source of agreed-upon language for a starting point, including: Previous clinical trial agreements (CTAs) between the parties.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

ACRP blog

DECEMBER 27, 2022

It’s not news that the number and complexity of clinical research studies continues to grow as the workforce continues to dwindle. Astonishingly, clinical research turnover rates are nearly 30%, versus a 15% national average. Astonishingly, clinical research turnover rates are nearly 30%, versus a 15% national average.

Research 52

Research Clinical Trials Clinical Trials Production 52

Drug Discovery World

OCTOBER 10, 2022

As a result, many apparently attractive new drug candidates in neuroscience subsequently fail to meet their primary endpoints in clinical trials. However, current drug pipelines do not always meet the growth expectations of their shareholders for discovering cost-effective and efficacious new therapies.

Development 52

Development Drugs Clinical Trials Clinical Trials 52

Drug Discovery World

DECEMBER 15, 2022

As gene editing technologies like CRISPR progress toward clinical study, researchers must continue to advance new approaches and address inherent challenges, explains Jon Chesnut, PhD, Senior Director, Cell Biology R&D, Thermo Fisher Scientific. Early phase clinical trials for gene editing therapies.

Gene Editing 52

Gene Editing Gene In-Vivo Genome 52

Drug Discovery World

JUNE 14, 2023

In acknowledgement of Blood Donor Day 2023, DDW spoke with industry experts about the significance of blood donorship in drug discovery. Bill Block, President & CEO of Blood Centers of America Bill Block is President and CEO of Blood Centers of America (BCA). million blood units annually, or 50% of the nation’s blood supply.

Manufacturing 52

Manufacturing Production Gene Therapy Development 52

Pharma in Brief

JANUARY 17, 2021

The asserted claims of the 437 Patent relate to pharmaceutical compositions comprising glatiramer acetate for particular uses in a patient who has had a single clinical attack suggestive of MS ( CIS patients ) and meets certain other criteria specified in the claims. Injunctive relief was granted in respect of the other patent. Anticipation.

Regulation 52

Regulation Production Trials Clinical Trials 52

The Pharma Data

DECEMBER 4, 2021

company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new medicines are developed, manufactured, and distributed for testing in clinical trials. (AWS), an Amazon.com, Inc.

Manufacturing 52

Manufacturing Development Drugs Clinical Supply Chain 52

Drug Discovery World

AUGUST 4, 2022

Susan A Darling, Senior Director, CE and Biopharma, SCIEX and Todd Stawicki, Senior Global Marketing Manager, Biopharma, SCIEX examine advanced analytical technologies can help ensure that biopharma candidates are commercialisable. To close this gap, developers of biotherapeutics need more information about their molecules far earlier.

Development 52

Development Protein Manufacturing Drugs 52

Drug Discovery World

OCTOBER 21, 2022

Thus, the technology has evolved from single-colour analysis to two-colours, then progressively increasing to eight, 16, and ultimately 20 to 30 colours with the most advanced traditional instruments 1. . Take, for example, its use for CD4 T cell counting to facilitate HIV monitoring. Overview, evolution, trends .

Reagent 52

Reagent Antibody Drugs Protein 52

The Pharma Data

MAY 13, 2021

Product Name: Which Arthritis Painkiller Works the Fastest? Click here to get Which Arthritis Painkiller Works the Fastest? at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. Which Arthritis Painkiller Works the Fastest?

Pharmacy 52

Pharmacy Production Doctors Doctor 52